PharmaTher

PharmaTher, a wholly-owned subsidiary of Newscope, is a specialized life sciences company focused on the research and development of psychedelic drugs. PharmaTher develops and commercializes an increasing number of specialty drugs, utilizing new delivery methods to enhance patient outcomes and streamline prescribing workflows for physicians. The company's leading product is KETARX™ (ketamine), addressing unmet medical needs in anesthesia, sedation, pain management, mental health, and neurological indications.